Boehringer's suction capability assessment program helps facilities meet their QAPI requirements.
Phoenixville, PA (PRWEB) March 06, 2012
On December 2, 2011, the Centers for Medicare & Medicaid Services (CMS) released a memo to hospitals regarding equipment maintenance requirements. In this memo, hospitals are expected to maintain equipment inventories and documentation of their maintenance activities. These monitoring activities should be included in the hospital-wide quality assessment and performance improvement (QAPI) program and will be reviewed during the hospital's accreditation audit by organizations such as the Joint Commission (JCAHO).
Scope of the Memo:
- “All equipment critical to patient health and safety including life-support devices, key resuscitation devices and any other device whose failure may result in serious injury or death of patients or staff.”
- “Any new equipment until a sufficient amount of maintenance history has been acquired.”
- Examples of included equipment: "Facility equipment (e.g., elevators, generators, air handlers, medical gas systems, air compressors and vacuum systems, etc.)” and “ Medical equipment (e.g., biomedical equipment, radiological equipment, patient beds, stretchers, IV infusion equipment, ventilators, laboratory equipment, etc.)”
A Full Copy of the CMS Memo can be found here:
Boehringer's suction capability assessment program helps facilities meet their QAPI requirements. The program will:
- Assess the compliance of wall suction inlets to the NFPA 99 standard and recommend needed service.
- Determine the basic functional operation of the medical suction equipment by performing a 7-point inspection of suction equipment in accordance with ISO, AACN and AARC Standards.
- Recommend appropriate clinical deployment of suction equipment in keeping with current professional practice guidelines to maximize a hospital's capital investment.
- Provide a detailed report, which meets the QAPI requirements, to the key stakeholders in the healthcare facility.
For more information on this assessment, please contact Boehringer Laboratories.